Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Retinal Diseases
Related studies linked through entity extraction aliases.
Long-Term Follow-Up Gene Therapy Study for Leber Congenital Amaurosis OPTIRPE65 (Retinal Dystrophy Associated With Defects in RPE65)
- Status
- COMPLETED
- Phase
- N/A
Advanced OCT and Adaptive Optics Imaging in Retinal Disease (The ACAD Study)
- Status
- COMPLETED
- Phase
- N/A
Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE4
Long-Working Distance OCT for Children
- Status
- COMPLETED
- Phase
- NA
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
- Status
- COMPLETED
- Phase
- PHASE1
DISCOVER Study: Microscope-integrated Intraoperative OCT Study
- Status
- RECRUITING
- Phase
- N/A
X-82 to Treat Age-related Macular Degeneration
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Evaluation of the RAVI-Guide
- Status
- COMPLETED
- Phase
- N/A
Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE3
Measuring Corneal Cells With Specular Microscopy
- Status
- COMPLETED
- Phase
- N/A
Microcurrent Stimulation to Treat Macular Degeneration
- Status
- COMPLETED
- Phase
- N/A
Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
GW824575 First Time in Human
- Status
- TERMINATED
- Phase
- PHASE1
An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
- Status
- UNKNOWN
- Phase
- PHASE2
Spectral Domain Optical Coherence Tomography Imaging of the Eyes of Neonates
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa
- Status
- COMPLETED
- Phase
- PHASE2
Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2)
- Status
- TERMINATED
- Phase
- PHASE1
Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
- Status
- UNKNOWN
- Phase
- PHASE1
High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia
- Status
- COMPLETED
- Phase
- PHASE2